Nigella sativa and Trigonella foenum-graecum Supplemented Chapatis Safely Improve HbA1c, Body Weight, Waist Circumference, Blood Lipids, and Fatty Liver in Overweight and Diabetic Subjects: A Twelve-Week Safety and Efficacy Study

다국어 초록 (Multilingual Abstract)

In 2019, ∼ 463 million people globally had diabetes mellitus (DM), with China (25.1%), India (16.6%), and the United States (6.69%) representing nearly 50% of that total. The primary objectives of this exploratory study were to assess the safety and potential efficacy of Nigella sativa and fenugreek seed supplemented chapatis in overweight (OW) and type 2 DM subjects. Forty subjects (15/OW; 9/DM; 16/DM/OW) consumed two chapatis twice a day 6 days/week for a daily dose of 5.45 g of an N. sativa/fenugreek combination over 12 weeks with no changes in lifestyle or medications. Anthropometric, glycemic, and vascular variables were recorded at baseline and after 6 and 12 weeks. Glycated hemoglobin (HbA1c), plasma lipids, and complete metabolic profile were measured at baseline and termination. Compliance, estimated during twice-daily individual delivery of precooked chapatis, was 100%, with no significant adverse effects. At termination, body weights, body mass index, waist and hip circumferences, index of central obesity, HbA1c, fasting blood glucose, 2-h postprandial blood glucose, estimated average glucose over 12 weeks, total cholesterol (TC), non-high density lipoprotein (HDL) cholesterol, very low density lipoprotein (VLDL), and triglycerides (TG) were decreased (P < .05) over all subjects. Subjects with HbA1c ≥7.0 exhibited greater improvements in all glycemic variables than HbA1c <7.0 subjects. In addition, the decrease in HbA1c was positively correlated with decreases in (1) hepatic enzymes alkaline phosphatase (r = 0.301, P = .0067) and aspartate transaminase (r = 0.277, P = .0129), (2) systolic blood pressure (r = 0.388, P = .0004), and (3) number of diagnostic metabolic syndrome criteria exhibited per subject (r = 0.391, P = .0005), cardiovascular risk score (CRS) (r = 0.281, P = .0115), and hepatic steatosis index (HSI) (r = 0.223, P = .0467). Atherogenic and diabetogenic indexes TC/HDL, low density lipoprotein/HDL, VLDL/HDL, and TG/HDL were all decreased (P < .05). Among all subjects, improvement (P < .05) was seen in CRS (−10.7%), fatty liver index (−19.8%), lipid accumulation product (−13.8%), and HSI (−7.53%). N. sativa/fenugreek supplemented chapatis present a safe and seamless dietary modification to address cardiometabolic risk.

참고문헌 (Reference)

1 Blagojevic IP, "Women with polycystic ovary syndrome and risk of cardiovascular disease" 36 : 259-269, 2017

2 Parimala KR, "Wheat-based traditional flat breads of India" 55 : 67-81, 2015

3 Lin MS, "Waist-to-height ratio is a useful index for nonalcoholic fatty liver disease in children and adolescents:A secondary data analysis" 17 : 851-, 2017

4 Sultan MT, "Utilization of Nigella sativa L. essential oil to improve the nutritive quality and thymoquinone contents of baked products" 11 : 910-915, 2012

5 Robert SD, "Trigonella foenumgraecum seeds lowers postprandial blood glucose in overweight and obese individuals" 2014 : 964873-, 2014

6 Vega GL, "Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men" 62 : 345-349, 2014

7 Yunke Z, "Triglyceride-to-HDL cholesterol ratio. Predictive value for CHD severity and new-onset heart failure" 39 : 105-110, 2014

8 Zonszein J, "Triglyceride high-density lipoprotein ratios predict glycemia-lowering in response to insulin sensitizing drugs in type 2 diabetes: A post hoc analysis of the BARI 2D" 2015 : 129891-, 2015

9 Nathan DM, "Translating the A1C assay into estimated average glucose values" 33 (33): 1473-1478, 2008

10 Irace C, "Transaminase levels in the upper normal range are associated with oral hypoglycemic drug therapy failure in patients with type 2 diabetes" 49 : 193-197, 2012

11 Kahn HS, "The ‘‘lipid accumulation product’’ performs better than the body mass index for recognizing cardiovascular risk: A population-based comparison" 5 : 26-, 2005

12 Harland JI, "Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol" 200 : 13-27, 2008

13 Li G, "Small dense low density lipoprotein-cholesterol and cholesterol ratios to predict arterial stiffness progression in normotensive subjects over a 5-year period" 17 : 27-, 2018

14 Ray S, "Serum lipoprotein ratios as markers of insulin resistance: A study among non-diabetic acute coronary syndrome patients with impaired fasting glucose" 141 : 62-67, 2015

15 Zarvandi M, "Safety and efficacy of a polyherbal formulation for the management of dyslipidemia and hyperglycemia in patients with advanced-stage of type-2 diabetes" 89 : 69-75, 2017

16 Zheng RD, "Role of body mass index, waist-to-height and waist-to-hip ratio in prediction of nonalcoholic fatty liver disease" 2012 : 362147-, 2012

17 Alireza Tavakkoli, "Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone" 대한약침학회 20 (20): 179-193, 2017

18 Robert SD, "Reduction of postprandial blood glucose in healthy subjects by buns and flatbreads incorporated with fenugreek seed powder" 55 : 2275-2280, 2016

19 Tauseef M, "Preparation and evaluation of dietetic cookies for vulnerable segments using black cumin fixed oil" 10 : 451-456, 2011

20 Michel CG, "Phytochemical and biological investigation of the extracts of Nigella sativa L. seed waste" 3 : 245-254, 2011

21 Al-Jenoobi FI, "Pharmacokinetic interaction studies of fenugreek with CYP3A substrates cyclosporine and carbamazepine" 39 : 147-153, 2014

22 Qaseem A, "Oral pharmacologic treatment of type 2 diabetes mellitus: A clinical practice guideline update from the American College of Physicians" 166 : 279-290, 2017

23 Hooda S, "Nutritional evaluation of wheat-fenugreek blends for product making" 59 : 149-154, 2004

24 Castera L, "Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease" 156 : 1264-1281, 2019

25 Lonardo A, "Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome" 47 : 181-190, 2015

26 Sultan MT, "Nigella sativa L. fixed oil supplementation improves nutritive quality, tocopherols and thymoquinone contents of cookies" 114 : 966-977, 2012

27 Yimer EM, "Nigella sativa L. (black cumin): A promising natural remedy for wide range of illnesses" 2019 : 1528635-, 2019

28 Valsamakis G, "Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines" 53 : 430-434, 2004

29 Marcum ZA, "Medication adherence to multidrug regimens" 28 : 287-300, 2012

30 Millan J, "Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention" 5 : 757-765, 2009

31 Wen J, "Lipoprotein ratios are better than conventional lipid parameters in predicting arterial stiffness in young men" 19 : 771-776, 2017

32 Hallsworth K, "Lifestyle modification in NAFLD/NASH: Facts and figures" 1 : 468-479, 2019

33 Garcia-Molina L, "Improving type 2 diabetes mellitus glycaemic control through lifestyle modification implementing diet intervention: A systematic review and meta-analysis" 59 : 1313-1328, 2020

34 Ramachandran A, "High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey" 44 : 1094-1101, 2001

35 Yarnell E, "Herbal medicine and nonalcoholic fatty liver disease" 16 : 15-21, 2010

36 Lee JH, "Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease" 42 : 503-508, 2010

37 Saeedi P, "Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition" 157 : 107843-, 2019

38 Zheng Y, "Global aetiology and epidemiology of type 2 diabetes mellitus and its complications" 14 : 88-98, 2018

39 Wani SA, "Fenugreek: A review on its nutraceutical properties and utilization in various food products" 17 : 97-106, 2018

40 Jack N. Losso, "Fenugreek Bread: A Treatment for Diabetes Mellitus" 한국식품영양과학회 12 (12): 1046-1049, 2009

41 Yadav D, "Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study" Medicine e4447-, 2016

42 Cheng YL, "Fatty liver index and lipid accumulation product can predict metabolic syndrome in subjects without fatty liver disease" 2017 : 9279836-, 2017

43 Jeon JY, "Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program" 9 : 1144-1152, 2018

44 Patel H, "Efficacy of dulaglutide as a first injectable option for patients with type 2 diabetes: A post-hoc pooled analysis" 10 : 2321-2330, 2019

45 Ahmad A, "Effects of thymoquinone on the pharmacokinetics and pharmacodynamics of glibenclamide in a rat model" 10 : 1395-1398, 2015

46 Hussain M, "Effects of Nigella sativa on various parameters in patients of non-alcoholic fatty liver disease" 29 : 403-407, 2017

47 Alireaz Mohtashami, "Effects of Bread with Nigella Sativa on Lipid Profiles, Apolipoproteins and Inflammatory Factor in Metabolic Syndrome Patients" 한국임상영양학회 5 (5): 91-97, 2016

48 Alireza Mohtashami, "Effects of Bread with Nigella Sativa on Blood Glucose, Blood Pressure and Anthropometric Indices in Patients with Metabolic Syndrome" 한국임상영양학회 8 (8): 138-147, 2019

49 Memon AR, "Effect of combination of Nigella sativa and Trigonella foenum-graecum with glibenclamide on serum triglyceride, HDL and creatinine levels in type-2 diabetes mellitus patients" 29 : 1-6, 2012

50 Memon AR, "Effect of combination of Nigella sativa and Trigonella foenum-graecum seeds with glibenclamide on body mass index in type-2 diabetes mellitus patients" 2 : 10-15, 2010

51 Memon AR, "Effect of combination of Nigella sativa and Trigonella foenum-graecum seeds with glibenclamide on blood sugar levels in type-2 diabetes mellitus patients" 2 : 46-51, 2010

52 Forouhi NG, "Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK" 49 : 2580-2588, 2006

53 Satija A, "Differences in consumption of food items between obese and normal-weight people in India" 25 : 10-13, 2012

54 Kaur P, "Current strategies and drug targets in the management of type 2diabetes mellitus" 19 : 1738-1766, 2018

55 Babish JG, "Compositions from Nigella sativa"

56 Ray L, "Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in indian population" 16 : 240-245, 2018

57 Kandhare AD, "A systematic literature review of fenugreek seed toxicity by using ToxRTool: Evidence from preclinical and clinical studies" 5 : e01536-, 2019

58 Nagulapalli Venkata KC, "A small plant with big benefits: Fenugreek (Trigonella foenumgraecum Linn.) for disease prevention and health promotion" 61 : 2017

59 Gowda S, "A review on laboratory liver function tests" 3 : 17-17, 2009

60 Huang PL, "A comprehensive definition for metabolic syndrome" 2 : 231-237, 2009

61 Matthew L. Tripp, "A Low-Glycemic, Mediterranean Diet and Lifestyle Modification Program with Targeted Nutraceuticals Reduces Body Weight, Improves Cardiometabolic Variables and Longevity Biomarkers in Overweight Subjects: A 13-Week Observational Trial" 한국식품영양과학회 22 (22): 479-489, 2019

62 Williams B, "2018 ESC/ESH guidelines for the management of arterial hypertension" 72 : 160-, 2019

63 Goff DC Jr., "2013 ACC/-AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines" 63 (63): 2935-2959, 2014